English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [1163]
News [2569]
Articles [163]
Editorials [8]
Conferences [104]
elearning [18]
Why cancer immunotherapy fails: Researchers link it to protein quality control collapse
Why cancer immunotherapy fails: Researchers link it to protein quality control collapse
Kidney cancer cases are projected to double by 2050, says study
Kidney cancer cases are projected to double by 2050, says study
ASTRO 2025: New therapy delays progression of recurrent prostate cancer
ASTRO 2025: New therapy delays progression of recurrent prostate cancer
Study finds most cancer patients exposed to misinformation. Researchers pilot 'information prescription.'
Study finds most cancer patients exposed to misinformation. Researchers pilot 'information prescription.'
New PET tracer enables same-day imaging of triple-negative breast and urothelial cancers
New PET tracer enables same-day imaging of triple-negative breast and urothelial cancers
Study identifies candidates for therapeutic targets in paediatric germ cell tumours
Study identifies candidates for therapeutic targets in paediatric germ cell tumours
NRG Oncology PREDICT-RT study completes patient accrual, tests individualised concurrent therapy and radiation for high-risk prostate cancer
NRG Oncology PREDICT-RT study completes patient accrual, tests individualised concurrent therapy and radiation for...
New hurdle seen to prostate screening: primary-care docs
New hurdle seen to prostate screening: primary-care docs
Millions of men could benefit from faster scan to diagnose prostate cancer
Millions of men could benefit from faster scan to diagnose prostate cancer
FDA approves gemcitabine intravesical system for non-muscle invasive bladder cancer
FDA approves gemcitabine intravesical system for non-muscle invasive bladder cancer
<12345...257>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top